Sign up to our newsletter Subscribe
A Case Study Analysis: Challenges in the NICE Evaluation of Multi-Indication Medicines for Rare and Ultra-Rare Diseases

Comment, press releases and other news from OHE.
Our monthly Bulletin highlights our work alongside the latest from across health economics and health care.